Literature DB >> 21105029

A pooled analysis of 14 cohort studies of anthropometric factors and pancreatic cancer risk.

Jeanine M Genkinger1, Donna Spiegelman, Kristin E Anderson, Leslie Bernstein, Piet A van den Brandt, Eugenia E Calle, Dallas R English, Aaron R Folsom, Jo L Freudenheim, Charles S Fuchs, Graham G Giles, Edward Giovannucci, Pamela L Horn-Ross, Susanna C Larsson, Michael Leitzmann, Satu Männistö, James R Marshall, Anthony B Miller, Alpa V Patel, Thomas E Rohan, Rachael Z Stolzenberg-Solomon, Bas A J Verhage, Jarmo Virtamo, Bradley J Willcox, Alicja Wolk, Regina G Ziegler, Stephanie A Smith-Warner.   

Abstract

Epidemiologic studies of pancreatic cancer risk have reported null or nonsignificant positive associations for obesity, while associations for height have been null. Waist and hip circumference have been evaluated infrequently. A pooled analysis of 14 cohort studies on 846,340 individuals was conducted; 2,135 individuals were diagnosed with pancreatic cancer during follow-up. Study-specific relative risks (RRs) and 95% confidence intervals (CIs) were calculated by Cox proportional hazards models, and then pooled using a random effects model. Compared to individuals with a body mass index (BMI) at baseline between 21-22.9 kg/m(2) , pancreatic cancer risk was 47% higher (95%CI:23-75%) among obese (BMI ≥ 30 kg/m(2) ) individuals. A positive association was observed for BMI in early adulthood (pooled multivariate [MV]RR = 1.30, 95%CI = 1.09-1.56 comparing BMI ≥ 25 kg/m(2) to a BMI between 21 and 22.9 kg/m(2) ). Compared to individuals who were not overweight in early adulthood (BMI < 25 kg/m(2) ) and not obese at baseline (BMI < 30 kg/m(2) ), pancreatic cancer risk was 54% higher (95%CI = 24-93%) for those who were overweight in early adulthood and obese at baseline. We observed a 40% higher risk among individuals who had gained BMI ≥ 10 kg/m(2) between BMI at baseline and younger ages compared to individuals whose BMI remained stable. Results were either similar or slightly stronger among never smokers. A positive association was observed between waist to hip ratio (WHR) and pancreatic cancer risk (pooled MVRR = 1.35 comparing the highest versus lowest quartile, 95%CI = 1.03-1.78). BMI and WHR were positively associated with pancreatic cancer risk. Maintaining normal body weight may offer a feasible approach to reducing morbidity and mortality from pancreatic cancer.
Copyright © 2010 UICC.

Entities:  

Mesh:

Year:  2011        PMID: 21105029      PMCID: PMC3073156          DOI: 10.1002/ijc.25794

Source DB:  PubMed          Journal:  Int J Cancer        ISSN: 0020-7136            Impact factor:   7.396


  40 in total

1.  Anthropometric and reproductive factors and the risk of pancreatic cancer: a case-control study in Shanghai, China.

Authors:  B T Ji; M C Hatch; W H Chow; J K McLaughlin; Q Dai; G R Howe; Y T Gao; J F Fraumeni
Journal:  Int J Cancer       Date:  1996-05-16       Impact factor: 7.396

Review 2.  Insulin resistance and obesity. The role of fat distribution pattern.

Authors:  N Abate
Journal:  Diabetes Care       Date:  1996-03       Impact factor: 19.112

3.  Risk factors for pancreatic cancer: an exploratory study.

Authors:  G D Friedman; S K van den Eeden
Journal:  Int J Epidemiol       Date:  1993-02       Impact factor: 7.196

4.  Validity of self-reported waist and hip circumferences in men and women.

Authors:  E B Rimm; M J Stampfer; G A Colditz; C G Chute; L B Litin; W C Willett
Journal:  Epidemiology       Date:  1990-11       Impact factor: 4.822

Review 5.  The underlying basis for obesity: relationship to cancer.

Authors:  George A Bray
Journal:  J Nutr       Date:  2002-11       Impact factor: 4.798

6.  Nutritional factors and pancreatic cancer: a case-control study from south-west Poland.

Authors:  W Zatonski; K Przewozniak; G R Howe; P Maisonneuve; A M Walker; P Boyle
Journal:  Int J Cancer       Date:  1991-05-30       Impact factor: 7.396

7.  Physical status: the use and interpretation of anthropometry. Report of a WHO Expert Committee.

Authors: 
Journal:  World Health Organ Tech Rep Ser       Date:  1995

8.  Comparison of self-reported and measured height and weight.

Authors:  M Palta; R J Prineas; R Berman; P Hannan
Journal:  Am J Epidemiol       Date:  1982-02       Impact factor: 4.897

9.  Validity of self-reported height and weight in 4808 EPIC-Oxford participants.

Authors:  Elizabeth A Spencer; Paul N Appleby; Gwyneth K Davey; Timothy J Key
Journal:  Public Health Nutr       Date:  2002-08       Impact factor: 4.022

10.  Physical activity, body weight, and pancreatic cancer mortality.

Authors:  I-M Lee; H D Sesso; Y Oguma; R S Paffenbarger
Journal:  Br J Cancer       Date:  2003-03-10       Impact factor: 7.640

View more
  90 in total

Review 1.  Obesity and pancreatic cancer: overview of epidemiologic evidence and biologic mechanisms.

Authors:  Paige M Bracci
Journal:  Mol Carcinog       Date:  2012-01       Impact factor: 4.784

Review 2.  Dairy products and pancreatic cancer risk: a pooled analysis of 14 cohort studies.

Authors:  J M Genkinger; M Wang; R Li; D Albanes; K E Anderson; L Bernstein; P A van den Brandt; D R English; J L Freudenheim; C S Fuchs; S M Gapstur; G G Giles; R A Goldbohm; N Håkansson; P L Horn-Ross; A Koushik; J R Marshall; M L McCullough; A B Miller; K Robien; T E Rohan; C Schairer; D T Silverman; R Z Stolzenberg-Solomon; J Virtamo; W C Willett; A Wolk; R G Ziegler; S A Smith-Warner
Journal:  Ann Oncol       Date:  2014-03-14       Impact factor: 32.976

3.  Pancreatic cancer incidence trends: evidence from the Surveillance, Epidemiology and End Results (SEER) population-based data.

Authors:  Vanessa L Gordon-Dseagu; Susan S Devesa; Michael Goggins; Rachael Stolzenberg-Solomon
Journal:  Int J Epidemiol       Date:  2018-04-01       Impact factor: 7.196

4.  Obesity-Induced Inflammation and Desmoplasia Promote Pancreatic Cancer Progression and Resistance to Chemotherapy.

Authors:  Joao Incio; Hao Liu; Priya Suboj; Shan M Chin; Ivy X Chen; Matthias Pinter; Mei R Ng; Hadi T Nia; Jelena Grahovac; Shannon Kao; Suboj Babykutty; Yuhui Huang; Keehoon Jung; Nuh N Rahbari; Xiaoxing Han; Vikash P Chauhan; John D Martin; Julia Kahn; Peigen Huang; Vikram Desphande; James Michaelson; Theodoros P Michelakos; Cristina R Ferrone; Raquel Soares; Yves Boucher; Dai Fukumura; Rakesh K Jain
Journal:  Cancer Discov       Date:  2016-05-31       Impact factor: 39.397

5.  Serum C-peptide, Total and High Molecular Weight Adiponectin, and Pancreatic Cancer: Do Associations Differ by Smoking?

Authors:  Leticia M Nogueira; Christina C Newton; Michael Pollak; Debra T Silverman; Demetrius Albanes; Satu Männistö; Stephanie J Weinstein; Eric J Jacobs; Rachael Z Stolzenberg-Solomon
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2017-01-17       Impact factor: 4.254

6.  Proportion of Cancer Cases Attributable to Excess Body Weight by US State, 2011-2015.

Authors:  Farhad Islami; Ann Goding Sauer; Susan M Gapstur; Ahmedin Jemal
Journal:  JAMA Oncol       Date:  2019-03-01       Impact factor: 31.777

7.  Associations between metabolites and pancreatic cancer risk in a large prospective epidemiological study.

Authors:  Rachael Stolzenberg-Solomon; Andriy Derkach; Steven Moore; Stephanie J Weinstein; Demetrius Albanes; Joshua Sampson
Journal:  Gut       Date:  2020-02-14       Impact factor: 23.059

8.  Prior History of Pancreatitis Accelerates the Development of Pancreatic Adenocarcinoma.

Authors:  Anna Evans Phillips; Nilesh Shah; Amir A Borhani; Dhiraj Yadav; Randall E Brand
Journal:  Pancreas       Date:  2018 Nov/Dec       Impact factor: 3.327

9.  Body mass index and cancer incidence: the FINRISK study.

Authors:  Xin Song; Eero Pukkala; Tadeusz Dyba; Jaakko Tuomilehto; Vladislav Moltchanov; Satu Männistö; Pekka Jousilahti; Qing Qiao
Journal:  Eur J Epidemiol       Date:  2014-07-06       Impact factor: 8.082

10.  Association of body mass index and risk of death from pancreas cancer in Asians: findings from the Asia Cohort Consortium.

Authors:  Yingsong Lin; Rong Fu; Eric Grant; Yu Chen; Jung Eun Lee; Prakash C Gupta; Kunnambath Ramadas; Manami Inoue; Shoichiro Tsugane; Yu-Tang Gao; Akiko Tamakoshi; Xiao-Ou Shu; Kotaro Ozasa; Ichiro Tsuji; Masako Kakizaki; Hideo Tanaka; Chien-Jen Chen; Keun-Young Yoo; Yoon-Ok Ahn; Habibul Ahsan; Mangesh S Pednekar; Catherine Sauvaget; Shizuka Sasazuki; Gong Yang; Yong-Bing Xiang; Waka Ohishi; Takashi Watanabe; Yoshikazu Nishino; Keitaro Matsuo; San-Lin You; Sue K Park; Dong-Hyun Kim; Faruque Parvez; Betsy Rolland; Dale McLerran; Rashmi Sinha; Paolo Boffetta; Wei Zheng; Mark Thornquist; Ziding Feng; Daehee Kang; John D Potter
Journal:  Eur J Cancer Prev       Date:  2013-05       Impact factor: 2.497

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.